Skip to main content
. 2016 Mar 25;16(4):434. doi: 10.3390/s16040434

Table 4.

The Downs and Black Quality List [108].

Subscale Item Index Score
5 4 3 2 1 0
Reporting 1 Is the hypothesis/aim/objective of the study clearly described? - - - - Y N
2 Are the main outcomes to be measured clearly described in the Introduction or Methods section? - - - - Y N
3 Are the characteristics of the patients included in the study clearly described? - - - - Y N
4 Are the interventions of interest clearly described? - - - - Y N
5 Are the distributions of principal confounders in each group of subjects to be compared clearly described? - - - Y P N
6 Are the main findings of the study clearly described? - - - - Y N
7 Does the study provide estimates of the random variability in the data for the main outcomes? - - - - Y N
8 Have all important adverse events that may be a consequence of the intervention been reported? - - - - Y N
9 Have the characteristics of patients lost to follow-up been described? - - - - Y N
10 Have actual probability values been reported (e.g., 0.035 rather than <0.05) for the main outcomes except where the probability value is less than 0.001? - - - - Y N
External Validity 11 Were the subjects asked to participate in the study representative of the entire population from which they were recruited? - - - - Y N/UD
12 Were those subjects who were prepared to participate representative of the entire population from which they were recruited? - - - - Y N/UD
13 Were the staff, places, and facilities where the patients were treated, representative of the treatment the majority of patients receive? - - - - Y N/UD
Internal Validity-Bias 14 Was an attempt made to blind study subjects to the intervention they have received? - - - - Y N/UD
15 Was an attempt made to blind those measuring the main outcomes of the intervention? - - - - Y N/UD
16 If any of the results of the study were based on “data dredging”, was this made clear? - - - - Y N/UD
17 In trials and cohort studies, do the analyses adjust for different lengths of follow-up of patients, or in case-control studies, is the time period between the intervention and outcome the same for cases and controls? - - - - Y N/UD
18 Were the statistical tests used to assess the main outcomes appropriate? - - - - Y N/UD
19 Was compliance with the intervention/s reliable? - - - - Y N/UD
20 Were the main outcome measures used accurate (valid and reliable)? - - - - Y N/UD
Internal Validity-Confounding (Selection Bias) 21 Were the patients in different intervention groups (trials and cohort studies) or were the cases and controls (case-control studies) recruited from the same population? - - - - Y N/UD
22 Were study subjects in different intervention groups (trials and cohort studies) or were the cases and controls (case-control studies) recruited over the same period of time? - - - - Y N/UD
23 Were study subjects randomised to intervention groups? - - - - Y N/UD
24 Was the randomised intervention assignment concealed from both patients and health care staff until recruitment was complete and irrevocable? - - - - Y N/UD
25 Was there adequate adjustment for confounding in the analyses from which the main findings were drawn? - - - - Y N/UD
26 Were losses of patients to follow-up taken into account? - - - - Y N/UD
Power 27 Did the study have sufficient power to detect a clinically important effect where the probability value for a difference being due to chance is less than 5%? Size of smallest intervention group
> n8 n7n8 n5n6 n3n4 n1n2 < n1

-Note: Y: yes; P: partially; N: no; UD: unable to determine.